Corneal Perforation during Combination Chemotherapy including Cetuximab in a Patient with a History of Herpetic Keratitis.
Keiichi AomatsuKoji SugiokaAya Kodama-TakahashiMasahiko FukudaHiroshi MishimaShunji KusakaPublished in: Case reports in oncological medicine (2020)
We have presented the first case of cetuximab-related corneal perforation in a patient who had a history of recurrent herpetic keratitis. EGFR inhibitors, such as cetuximab, can induce corneal perforation in cases with a history of herpetic stromal keratitis.